Helius Medical Technologies ( (HSDT) ) has released a notification of late filing.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Solana Company, formerly known as Helius Medical Technologies, has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending September 30, 2025. The primary reason for this delay is the recent resignation of their independent registered public accounting firm, Baker Tilly US, LLP, and the subsequent appointment of CBIZ CPAs P.C. as the new auditor. This change has necessitated additional time to finalize the review of financial statements. The company expects to file the report within five calendar days following the prescribed due date. Significant changes in financial results are anticipated due to the adoption of a Solana-centric Digital Asset Treasury, although exact figures are not yet available. Solana Company is committed to compliance and is working diligently to complete the filing, as indicated by the signature of Jeffrey S. Mathiesen, Chief Financial Officer.
The most recent analyst rating on (HSDT) stock is a Sell with a $6.50 price target. To see the full list of analyst forecasts on Helius Medical Technologies stock, see the HSDT Stock Forecast page.
Spark’s Take on HSDT Stock
According to Spark, TipRanks’ AI Analyst, HSDT is a Underperform.
Helius Medical Technologies is currently facing significant financial and operational challenges. The most impactful factor is the poor financial performance, with consistent losses and negative cash flow. Technical analysis also indicates bearish momentum, with the stock trading below key moving averages and showing oversold conditions. Valuation metrics further highlight the company’s struggles, with a negative P/E ratio and no dividend yield. These factors collectively result in a low overall stock score.
To see Spark’s full report on HSDT stock, click here.
More about Helius Medical Technologies
Average Trading Volume: 992,683
Technical Sentiment Signal: Strong Sell
Current Market Cap: $216.8M
See more insights into HSDT stock on TipRanks’ Stock Analysis page.